regulatory_compliance

Coastal Property Investors Face Rising Insurance and Compliance Costs in South Florida

Image
Coastal Property Investors Face Rising Insurance and Compliance Costs in South Florida

Fort Lauderdale, Fla. – September 09, 2026 -- Coastal rental and multifamily property owners in South Florida face escalating insurance premiums, strict municipal rental rules, and elevated maintenance costs that directly affect cash flow, according to a new analysis featuring Howard Goldberg, Real Estate Expert with RE/MAX Consultants Realty 1.

Flood and wind coverage requirements drive up renewal costs for beachfront owners

Properties near the ocean typically require flood coverage, wind protection, and higher deductibles, expenses that can rise sharply at policy renewal. For multifamily assets, a single policy change affects multiple units simultaneously, increasing the need for financial buffers and consistent oversight across the portfolio.

US Court Voids Kaneka Ubiquinol Patent, Clears CrysQnol Ingredient

Image
US Court Voids Kaneka Ubiquinol Patent, Clears CrysQnol Ingredient

Jiaxing, China – September 09, 2026 -- The U.S. District Court for the Eastern District of New York has invalidated two patent claims Kaneka Corporation asserted against Cocrystal Technology (Jiaxing) Co., Ltd., ending a nearly three-year dispute and clearing the way for unrestricted U.S. sales of Cocrystal Tech's ubiquinol ingredient, now branded CrysQnolTM.

Korea's MFDS Closes GBC 2026 With 5,600 Attendees, 23 Regulator Meetings

Seoul – September 09, 2026 -- The Ministry of Food and Drug Safety of Korea (MFDS) concluded the 12th Global Bio Conference (GBC) on August 28, drawing roughly 5,600 participants from 19 countries to the Grand InterContinental Seoul Parnas for three days of talks on biopharmaceutical regulation and technology.

Forums drew hundreds of specialists across vaccines, proteins and advanced therapies

Held from August 26-28 under the theme 'The Great Leap in Bio, Accelerating Innovation,' the event featured 75 biopharmaceutical experts delivering presentations across specialized tracks. The Recombinant Protein Products Forum attracted 591 attendees, the Advanced Biopharmaceuticals Policy and Quality Forum drew 483, and the Vaccine Forum logged 462 participants, combining online and offline sessions.

FOTON Exports Jump 44.3% Ahead of Major IAA Hannover Unveiling

Image
FOTON Exports Jump 44.3% Ahead of Major IAA Hannover Unveiling

Beijing – September 09, 2026 -- FOTON exported 149,000 commercial vehicles between January and August 2026, a 44.3% year-on-year increase, as the Chinese manufacturer prepares to unveil its European strategy at IAA Transportation in Hannover on September 14.

FOTON has led Chinese commercial-vehicle exports for 15 consecutive years

The company has shifted from volume-driven exports to what it calls Globalization 3.0, a model integrating products, technology, manufacturing, supply chains and service networks rather than pure unit shipments.

ABDA Sets Munich Press Briefing on Pharmacy Reform Impact

Image
ABDA Sets Munich Press Briefing on Pharmacy Reform Impact

Munich – September 09, 2026 -- More than 300 delegates from Germany's 17 pharmacist chambers and associations will convene in Munich from September 15 to 17 for the German Pharmacists' Day (Deutscher Apothekertag, DAT) 2026, as the country's pharmacy reform moves from legislation into implementation.

CelluPro Becomes First China Cell Culture Media Maker With EXCiPACT GMP

Yantai – September 09, 2026 -- CelluPro has secured EXCiPACTTM GMP certification for pharmaceutical auxiliary materials, becoming the first China-based cell culture media supplier to achieve the credential.

CelluPro adds EXCiPACT GMP to existing ISO certification portfolio

The biotechnology firm, which specializes in serum-free cell culture media and bioprocessing solutions, now holds EXCiPACTTM certification alongside ISO 9001, ISO 13485, ISO 14001, ISO 45001 and ISO 22301 certifications covering quality management, environmental management, occupational health and safety, and business continuity.

Nutromics Names DNA-Sensor Inventor Plaxco as Chief Scientific Officer

Image
Nutromics Names DNA-Sensor Inventor Plaxco as Chief Scientific Officer

Melbourne – – September 09, 2026 -- Nutromics, a Melbourne-based wearable diagnostics startup, has appointed Professor Kevin W. Plaxco, the inventor of its core DNA-based sensing technology, as Chief Scientific Officer ahead of its first product launch planned for 2027.

Plaxco takes over as CSO from Justin Gooding, who remains on the Biosensor Advisory Board

Professor Plaxco succeeds Scientia Professor Justin Gooding in the role. Gooding will continue to serve on Nutromics' Biosensor Advisory Board, a group Plaxco previously chaired as an advisor since the company licensed his technology from co-founders Peter Vranes and Hitesh Mehta.

BYD's 20-Year Chip Bet Pays Off as China Pushes Auto Semiconductor Localization

Taipei – September 09, 2026 -- A new DIGITIMES Intelligence report finds that BYD's Xuanji A3 smart-driving system-on-chip has entered scaled production on a 4nm automotive-grade process, marking the culmination of a semiconductor strategy the company began building more than two decades ago.

BYD's chip roadmap moved from power devices to 4nm smart-driving silicon

BYD's semiconductor efforts started with IGBT and silicon carbide (SiC) power devices for electric-vehicle control systems, according to the report. That foundation has since expanded into higher-compute automotive SoCs, positioning the Xuanji A3 as a flagship product of a vertically integrated manufacturing model spanning chip design, wafer fabrication and mass production across multiple in-house fabs.

Nuix Rolls Out Generative AI Suite, Debuts AI Chat for Legal Review

Sydney – September 09, 2026 -- Nuix has made its Generative AI capabilities generally available in Nuix Discover SaaS as of September 4, adding Document Summaries, Similar Documents, Semantic Search, Clustering and Visualizations to its legal review and eDiscovery platform.

Nuix launches AI Chat in Early Adopter release, targeting full availability in December 2026

The new conversational tool lets reviewers, attorneys and investigators query case data in natural language and receive synthesized answers sourced directly from document content. Every response includes citations to source documents, and all interactions are logged to create a court-ready audit trail.

"AI Chat lets teams simply ask questions and get answers grounded in their case data; answers that are defensible and auditable. That's the standard the legal profession demands, and it's what sets Nuix apart," said Ilona Meyer, Executive Vice President, Nuix Discover.